News

An artificial-intelligence approach created at the University of North Carolina at Chapel Hill Eshelman School of Pharmacy can teach itself to design new drug molecules from scratch and has the potential to dramatically accelerate the design of new drug candidates.

Antibody production from three cell lines will provide valuable opportunities for researchers and manufacturers.

Inhibiting a previously known protein could reduce tumor burdens and enhance the effectiveness of immunotherapy treatments, according to new research.

The NIH has launched a new initiative to harness the power of commercial cloud computing and provide NIH biomedical researchers access to the most advanced, cost-effective computational infrastructure, tools and services available.

This is the first time a signaling protein has been shown to control its own transport mechanism.

In a finding that could point the way toward better computer vision systems, Brown University researchers show why computers are so bad at seeing when one thing is not like another.

Investigators have used an experimental compound in mice to successfully reverse hair loss, hair whitening and skin inflammation linked by previous studies to human diets heavy in fat and cholesterol.

A gene that's associated with an autoimmune form of hair loss could be exploited to improve cancer immunotherapy, suggests a new mouse study by Columbia University Irving Medical Center (CUIMC) researchers.

New device could quickly detect disease-causing bacteria and save lives.

New research has shown that ovarian cancer patients with a tumor mutation in the BRAF gene respond exceptionally well to treatment with targeted drugs, known as BRAF inhibitors.